Cargando…

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

BACKGROUND: BPI-9016M is a novel small-molecule inhibitor that simultaneously targets both c-Met and AXL tyrosine kinases. This phase I study aimed to determine the maximum tolerated dose (MTD), safety, pharmacokinetics, and antitumor activity of BPI-9016M in Chinese patients with advanced non-small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xingsheng, Zheng, Xin, Yang, Sheng, Wang, Lin, Hao, Xuezhi, Cui, Xinge, Ding, Lieming, Mao, Li, Hu, Pei, Shi, Yuankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966871/ https://www.ncbi.nlm.nih.gov/pubmed/31948451 http://dx.doi.org/10.1186/s13045-019-0834-2

Ejemplares similares

Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
por: Hu, Xingsheng, et al.
Publicado: (2023)

BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1
por: Zhang, Panpan, et al.
Publicado: (2018)

Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Jiang, Chenxue, et al.
Publicado: (2021)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

6250 BPI Magnetic Tape
Publicado: (2017)

Update on shoulder reconstruction in BPI
por: Doi, Kazuteru
Publicado: (2015)

Clinical and genomic analysis of baseline and acquired MET fusions with an intact kinase domain in lung cancer patients
por: Jin, Bo, et al.
Publicado: (2023)

6250 BPI Magnetic Tape Olivetti
Publicado: (2017)

Excited-State Dynamics of [Ru((S–S)bpy)(bpy)(2)](2+) to Form Long-Lived Localized Triplet States
por: Heindl, Moritz, et al.
Publicado: (2021)

Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study
por: Shi, Yuankai, et al.
Publicado: (2023)

Changes in the types of liver diseases requiring hepatic resection: a single-institution experience of 9016 cases over a 10-year period
por: Cho, Hwui-Dong, et al.
Publicado: (2016)

Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016
por: Perez Valero, Ignacio, et al.
Publicado: (2020)

Evidence for the Bpi decay mode of the omega(1670)
por: Baubillier, M, et al.
Publicado: (1979)

Serum BPI as a novel biomarker in asthma
por: Xingyuan, Chen, et al.
Publicado: (2020)

Gga3 gene-deleted C57BL/6J mice have elevated fasting blood glucose levels
por: Zhang, Xiaohong, et al.
Publicado: (2023)

Identification and Functional Analysis of ToBPI1/LBP and ToBPI2/LBP in Anti-Bacterial Infection of Trachinotus ovatus
por: Bian, Ze-Chang, et al.
Publicado: (2023)

Particle Size-Controlled Oxygen Reduction and Evolution Reaction Nanocatalysts Regulate Ru(bpy)(3)(2+)’s Dual-potential Electrochemiluminescence for Sandwich Immunoassay
por: Wang, Shijun, et al.
Publicado: (2023)

Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma
por: Hu, Dingtao, et al.
Publicado: (2023)

Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors
por: Ma, Yu-Xiang, et al.
Publicado: (2022)

A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
por: Liu, Lian, et al.
Publicado: (2013)

A dual MET/AXL small‐molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironment
por: Zhu, Chenjing, et al.
Publicado: (2020)

6250 BPI IBM reduce version 3.3
Publicado: (1988)

Photochemistry of fac-[Re(bpy)(CO)(3)Cl]**
por: Sato, Shunsuke, et al.
Publicado: (2012)

Surface Enhanced Electrochemiluminescence of Ru(bpy)(3)(2+)
por: Wang, Daifang, et al.
Publicado: (2015)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
por: Takeda, Sayo, et al.
Publicado: (2019)

Electrocatalytic Semihydrogenation of Alkynes with [Ni(bpy)(3)](2+)
por: Lee, Mi-Young, et al.
Publicado: (2022)

AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells
por: Choi, Yun Jung, et al.
Publicado: (2015)

Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis
por: Hsu, Tung-Wei, et al.
Publicado: (2023)

Clinical significance of BPI‐ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization
por: Tian, Yongjian, et al.
Publicado: (2019)

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
por: Wang, Feng-Hua, et al.
Publicado: (2021)

Influence of Martensite/Bainite Dual Phase-Content on the Mechanical Properties of EA4T High-Speed Axle Steel
por: Zhang, Yan, et al.
Publicado: (2023)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

Crystal structures of three copper(II)–2,2′-bipyridine (bpy) compounds, [Cu(bpy)(2)(H(2)O)][SiF(6)]·4H(2)O, [Cu(bpy)(2)(TaF(6))(2)] and [Cu(bpy)(3)][TaF(6)](2) and a related coordination polymer, [Cu(bpy)(H(2)O)(2)SnF(6)](n)
por: Nisbet, Matthew L., et al.
Publicado: (2021)

Estimation of states and parameters of multi-axle distributed electric vehicle based on dual unscented Kalman filter
por: Pei, Xiaofei, et al.
Publicado: (2019)

Mechanisms Underlying Footshock and Psychological Stress-Induced Abrupt Awakening From Posttraumatic “Nightmares”
por: Yu, Bin, et al.
Publicado: (2015)

Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
por: Li, Guodong, et al.
Publicado: (2023)

Mesenchymal stem cells alleviate airway inflammation via modulation of T-helper 17/regulatory T cells balance in mice with ovalbumin-induced asthma
por: Zeng, Shao-Lin, et al.
Publicado: (2021)

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma
por: Hagege, Anais, et al.
Publicado: (2022)

AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma
por: Zito Marino, Federica, et al.
Publicado: (2022)

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
por: Paz-Ares, Luis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s48t5qrestrko64qc2uft1h7r8